Dental Care Clinics in Marlette, MI Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Marlette Fam Dentistry Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 3149 Main St, Marlette, MI 48453 Phone: 989-635-7541 Fax: 989-635-2414 |
Heart Of The Thumb Dentistry Dentist Medicare: Not Enrolled in Medicare Practice Location: 2621 Main St, Marlette, MI 48453 Phone: 989-635-7411 Fax: 989-635-7413 |
News Archive
International studies show high efficacy for Gardasil
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer, strains 16 and 18.
Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows
A study published in the New England Journal of Medicine on 20th July 2017 suggests that a cocktail of drugs, if provided at the beginning of the HIV therapy, can save over 10,000 lives per year. HIV, which is often diagnosed late, leaves people vulnerable to other diseases by ravaging the immune system.
Middle-life hypertension may shrink the brain in later life
A long-running study which ha been following up people into their seventies concludes that high blood pressure between the age of 36 and 53 years is associated with brain pathology such as white matter lesions and brain shrinkage in later life. To prevent this, blood pressure should be monitored beginning at or before 40 years, suggest the researchers.
Pernix completes Macoven acquisition
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced the acquisition of 100% of the outstanding membership interest in Macoven Pharmaceuticals, L.L.C. for approximately $2.2 million (which includes inventory of approximately $1.2 million), its entry into a $10 million credit facility with Regions Bank and the repurchase of 2,000,000 shares of its common stock from one of its employees in a privately negotiated transaction.
Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS
On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS.
› Verified 7 days ago